Table 1

Comparison of patients according to whether they received empiric antifungal (AF) therapy or not

Total
(n=554)
Empiric AF
(n=239)
No empiric AF
(n=315)
P value
Age (year), mean±SD (median)56.7±17.8 (57.0)56.8±18.4 (58.0)56.6±17.3 (57.0)0.909
Male60.5% (335/554)59.8% (143/239)61.0% (192/315)0.789
CCI, mean±SD (median)4.0±3.7 (3.0)4.1±3.5 (3.0)4.0±3.9 (3.0)0.744
Previous PUD23.7% (131/553)25.1% (60/239)22.6% (71/314)0.495
Steroid use9.4% (52/553)11.7% (28/239)7.6% (24/314)0.104
PPI use18.1% (100/553)20.9% (50/239)15.9% (50/314)0.130
Pneumoperitoneum94.9% (525/553)97.1% (231/238)93.3% (294/315)0.048
Fever >38 C4.4% (24/546)5.5% (13/237)3.6% (11/309)0.277
Laparoscopic approach23.5% (130/554)23.4% (56/239)23.5% (74/315)0.751
Surgery type
 Omental patch78.3% (434/554)79.5% (190/239)77.5% (244/315)0.843
 Gastrectomy4.5% (25/554)4.2% (10/239)4.8% (15/315)
 Other17.1% (95/554)16.3% (39/239)17.8% (56/315)
Surgical drain at index surgery51.9% (287/553)56.5% (135/239)48.4% (152/314)0.060
Blood cultures at admission (+) for Candida spp7.9% (13/164)6.8% (6/88)9.2% (7/76)0.572
IP cultures obtained at index surgery31.9% (177/554)39.7% (95/239)26.0% (82/315)0.001
 IP cultures (+) for Candida spp42.9% (76/177)46.3% (44/95)39.0% (32/82)0.328
  • P values were obtained from t-test or Mann-Whitney test for continuous variables, and from χ2 or Fisher’s exact test for dichotomous variables.

  • CCI, Charlson Comorbidity Index; IP, intraperitoneal; PPI, proton pump inhibitor; PUD, peptic ulcer disease.